What patients and payers pay for 340B drugs: 6 study notes
An October report from Berkeley Research Group estimates how much patients and payers spend on 340B drugs, beyond what covered entities pay to acquire them. Here are six findings to know: The post What patients and payers pay for 340B drugs: 6 study notes appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.